STAT+: FDA’s expansive Alzheimer’s drug approval surprised even top agency officials
WASHINGTON — The Food and Drug Administration’s contentious decision to approve a new Alzheimer’s drug…
Category: Politics
.jpg)
Smokers of menthol cigarettes have a harder time quitting, large new study finds
A new study published Tuesday finds that smoking menthol cigarettes versus unflavored cigarettes is associated…
STAT+: Is the Alzheimer’s Association really pushing Biogen to lower its new drug’s price — or is it lip service?
WASHINGTON — The Alzheimer’s Association stunned Washington last month when it urged Biogen to lower…
STAT+: Supreme Court to take up hospitals’ challenge to Medicare drug pay cuts
WASHINGTON — In a win for safety-net hospitals, the Supreme Court decided to hear their…
STAT+: Washington’s antitrust push could limit Amazon, Google’s health care ambitions
WASHINGTON — Washington is abuzz with an ambitious new antitrust effort to rein in the…
Will Biogen’s new Alzheimer’s drug’s burden on Medicare be big, huge, or catastrophic?
The Food and Drug Administration’s decision to grant wide-ranging approval to the controversial, pricey new…
STAT+: House leaders to investigate FDA approval and price of Biogen’s Alzheimer’s drug
WASHINGTON — The top House Democrats on two powerful committees on Friday announced an investigation…
Perna set to retire from Warp Speed later this summer
WASHINGTON — Gus Perna, the four-star Army general responsible for coordinating the U.S. coronavirus vaccine…
STAT+: FDA’s Woodcock is just ‘not that concerned’ about the criticism over Biogen’s Alzheimer’s drug, Aduhelm
WASHINGTON — The Food and Drug Administration has been without a permanent commissioner for six…
STAT+: Bipartisan pair of senators calls on Congress to examine expensive new Alzheimer’s drug
WASHINGTON — Sens. Elizabeth Warren (D-Mass.) and Bill Cassidy (R-La.) want Congress to take a…
Key Democrats slam FDA for failing to crack down on Juul and other e-cigarette makers
WASHINGTON — Congressional Democrats openly pressured acting Food and Drug Administration Commissioner Janet Woodcock to…
.jpg)
STAT+: Key science officials detail their plans for a new research agency — and Congress is getting closer to funding it
WASHINGTON — Two key federal health officials are pitching a new branch of the National…
STAT+: Powerful Democrat’s new drug pricing manifesto hints at a carveout for small biotechs
WASHINGTON — Sen. Ron Wyden (D-Ore.), the influential chair of the Senate Finance Committee, is…
STAT+: Biogen isn’t the only drug company that will profit from the new Alzheimer’s drug Aduhelm
WASHINGTON — Biogen’s expecting to make billions from its newly approved Alzheimer’s drug Aduhelm. But…
STAT+: BIO’s chief on the FDA commissioner rumors, drug pricing, and IP rights
WASHINGTON — Everyone wants to know whether Michelle McMurry-Heath, the newly minted president of the…
STAT+: Former FDA chief Hahn defends his jump to Flagship Pioneering, the firm behind Moderna
When biotech investor Flagship Pioneering announced that it had hired former Food and Drug Administration…
STAT+: Biden administration moves to axe Trump 340B rule targeting community clinics
WASHINGTON — The Biden administration on Tuesday moved to axe a Trump-era policy that would…
STAT+: Buying the data: Health care lobbyists fund their own policy analyses, clouding Washington debates
WASHINGTON — Sen. Chuck Grassley’s voice boomed through the Senate hearing room — it sounded…
More than two-thirds of Congress cashed a pharma campaign check in 2020, new STAT analysis shows
WASHINGTON — Seventy-two senators and 302 members of the House of Representatives cashed a check…
Pharma funded more than 2,400 state lawmaker campaigns in 2020, new STAT analysis finds
WASHINGTON — State lawmakers in Oregon have tried to lower high drug prices from nearly…
STAT+: Despite its high price tag, the new Alzheimer’s drug isn’t reigniting the drug pricing debate
WASHINGTON — It has all the makings of a bombastic drug pricing debate: a highly…
STAT+: By approving Biogen’s Alzheimer’s drug, the FDA is shifting its rules. That is a giant risk
In order to approve a new Alzheimer’s treatment, the Food and Drug Administration is rewriting…
STAT+: Drug makers argue an HHS rule would penalize them for offering co-pay coupons
After months of controversy, the pharmaceutical industry’s biggest trade group has filed a lawsuit accusing…
STAT+: Health care providers hope to cash in through Congress’ new earmark process
WASHINGTON — Earmarks are back, and so is the health care industry’s insatiable appetite to…
California could become first state to mandate biosecurity screening by mail-order DNA companies
California lawmakers on Thursday will vote on a bill that would require the state’s growing…
STAT+: Democrats call on FTC to investigate AbbVie’s Humira pricing strategy
WASHINGTON — Three powerful Democrats wrote to the Federal Trade Commission Tuesday urging them to…
STAT+: Congress is ready to grill AbbVie’s CEO over drug pricing
WASHINGTON — AbbVie CEO Richard Gonzalez is in for a congressional tongue-lashing of outsized proportion….
STAT+: Abandoned Trump order on the bioeconomy highlights a path forward for Biden — but with mixed reviews
WASHINGTON — The Trump administration came remarkably close to shoring up the scattershot way the…
STAT+: Telehealth companies are fueling a lobbying frenzy to protect their Covid boom
WASHINGTON — Telehealth companies, flush with cash after the Covid-19 pandemic spiked both demand and…
STAT+: Pharma showers Menendez with rare, off-cycle burst of campaign cash as Democrats eye drug pricing reforms
WASHINGTON — Sen. Bob Menendez doesn’t face reelection until 2024, but pharmaceutical executives are already…
White House aims to give 70% of American adults at least one vaccine dose by July 4
WASHINGTON — The Biden administration on Tuesday set a new goal for the ongoing U.S….
STAT+: Biden’s Medicaid pressure tactics could put his team at odds with hospitals
WASHINGTON — The Biden administration is pressuring states to expand Medicaid — and it’s setting…
STAT+: Top Senate Democrat heads back to drawing board on drug pricing
WASHINGTON — A powerful Democratic committee chair is starting to work on a new drug…
Do public health officials need to be political activists? A fight over an HIV crisis renews the question
Most local health officials don’t accept their jobs expecting to be roped into political activism….
STAT+: Lander fends off controversy, pledges broader access to STEM careers during Senate confirmation hearing
WASHINGTON — Eric Lander, President Biden’s nominee to lead the White House’s science policy office,…
In his biggest speech yet, Biden pitches a new health agency to help ‘end cancer as we know it’
WASHINGTON — In one of the most emotional moments of his first major address to…
Biden is set to ask for drug pricing reform this year. But it’s an empty call
WASHINGTON — President Biden is set to tell Congress tonight to let Medicare negotiate drug…
Biden administration will allow nearly all providers to prescribe buprenorphine
WASHINGTON — The Biden administration on Tuesday announced it would move forward with a dramatic…
STAT+: Drug pricing déjà vu: Now it’s Democrats struggling to unite on the issue
WASHINGTON — It’s the eve of a major speech by the president, and it’s anyone’s…
STAT+: The FDA will this week decide whether to ban menthol cigarettes — but most likely, the fight is just getting started
WASHINGTON — The Food and Drug Administration will decide this week whether to ban menthol…
STAT+: Worried drug pricing reform might be left behind, Democrat pushes Biden to make clear his support
WASHINGTON — At least one Democratic lawmaker is openly pushing President Biden to include drug…
STAT+: Why hospitals hate Bernie Sanders’ latest health reform push
WASHINGTON — Progressives in Congress, led by Sen. Bernie Sanders, have ramped up pressure on…
STAT+: Pfizer shareholders are urged to reject political spending that contradicts ‘company values’
Arguing that Pfizer’s political spending conflicts with the company’s publicly stated values, a philanthropic organization…
Top Senate Republican holds up Biden’s CMS nominee over Texas Medicaid waiver
WASHINGTON — A top Senate Republican is holding up the confirmation of President Biden’s nominee…
STAT+: Biden officials met privately with 3M, AmerisourceBergen, PhRMA and more to debate shoring up the national stockpile
WASHINGTON — The Biden administration met privately this month with some of the nation’s biggest…
STAT+: The lobbying juggernaut the American Hospital Association is losing its top advocate at a critical moment for the industry
WASHINGTON — Tom Nickels helped build the American Hospital Association into one of the biggest…
In Q&A, Vice President Harris calls for urgent action on the Black maternal health crisis
It’s an American crisis that was long ignored at the government’s highest levels: Black women…
STAT+: Hints emerge about a key Senate committee’s plans for health care
WASHINGTON — A Senate hearing Thursday provided one of the clearest roadmaps to date for…
Opinion: STAT+: Rethinking triage in an era of vaccine nationalism
Just about every schoolchild learns that Napoleon Bonaparte was a small man. But few know…
STAT+: PhRMA chief talks strategy — and he’s surprisingly optimistic about drug pricing reform
WASHINGTON — Steve Ubl, who leads the drug industry lobbying powerhouse PhRMA, has a bold…